Skip to content
Research Article Open access CC BY 4.0

Regulations for Testing and Licensing of Vaccines in United Kingdom

M. Ranjitha, H. R. Arjun, M. P. Venkatesh

Journal of Pharmaceutical Research International · pp. 25–32 · Published 20 May 2022

10.9734/jpri/2022/v34i38B36224

Abstract

Vaccines are one of the most significant achievements of science and public health for prevention of infectious disease. Overall vaccination policies for HCP in should be periodically revaluated in order to provide optimal protection against vaccine preventable diseases and infection control with in healthcare. The guidelines address ethical issues that arise during a vaccine study. A network of Adverse Drug Reaction (ADR) monitoring centre alone with adverse event following immunisation (AEFI) provide the machinery for vaccine pharmacovigilance.

Vaccine pharmacovigilance adverse drug reaction adverse event following immunization vaccine preventable disease

Cited by 0

No indexed citations yet.

Article metrics

Real usage data collected on this platform.

4

Page views

0

PDF downloads

0

Outbound clicks

0

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.